Select a State

Global health R&D delivers for Nevada

US government investment in global health R&D has delivered

$1.3 million
to Nevada research institutions

Neglected diseases in Nevada

Chikungunya cases
4
Dengue cases
21
HIV diagnoses
3,764
Malaria cases
44
Tuberculosis cases
808
West Nile cases
92
Zika cases
23

Nevada's top USG-funded global health R&D institutions

University of Nevada, Las Vegas
$883 thousand
University of Nevada, Reno
$396 thousand

Nevada industry in global health R&D

Charles River Laboratories
Location(s):
Reno
DX Discovery
Location(s):
Reno
Sanofi
Location(s):
Reno

Nevada's top areas of global health R&D by USG funding

100.0%
Diarrheal diseases

Global health R&D at work in Nevada

A team of scientists from three universities, including the University of Nevada, conducted research that uncovered how the bacteria Shigella causes shigellosis, a diarrheal disease that kills more than 1 million people each year. When Shigella bacteria invade a human host, environmental conditions stimulate a process within the bacteria that allows them to thrive. Central to this transformation are two proteins that work together to increase the bacteria’s harmfulness. The team found that production of one of the proteins can be controlled separately from the other, a discovery that could lead to new treatments. For large numbers of people living in low-income countries, targeted and improved antibiotics could mean the difference between life and death. No vaccine currently exists for Shigella.

Footnotes